Exosomes are biological nanoparticles known to mediate communication between cells; since they exert significant roles in various pathological conditions such as cancer, infectious and neurodegenerative diseases, their effective utilization holds a great promise of revolutionizing the standard of diagnostics and clinical care.
However, the clinical breakthrough exosomes may present in healthcare could not be realized to date due to difficulties in identifying and characterizing exosomes resulting from their small size (30-100nm).
The aim of Project INDEX is to isolate and characterize exosomes available in bodily fluids through development and integration of novel technological breakthroughs and accelerate the transition of exosome-based research and scientific discoveries to real clinical utility INDEX is funded by the European Commission in the framework of H2020 FET-OPEN programs and officially started October 1st 2017.
Consortium: 6 partners from 5 countries
Coordinator of the project: National Research Council (CNR)
Funding programme: Horizon 2020
Project start: 1st October 2017
End date for the project: 30 September 2020